AzTrials
AzTrials

Accommodation DisorderNCT06565091

Clinical Investigation for a Multifunction Ophthalmic Measurement Device

A study testing Measurements of physiological parameters of the anterior chamber and Measurements of the Axial biometry in people with Accommodation Disorder and Keratoconus, run by Essilor International at 1 site in France.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The purpose of this clinical investigation is to evaluate the clinical utility of a multifunctional measuring device for Ophtalmology. The results of this clinical investigation will be used to refine and validate the device design. Read more about this study

Who is it for?
Ages 4 years and olderHealthy volunteers can take part
Conditions the study is for
Accommodation Disorder, Keratoconus, Dry Eye
What is being tested?
Measurements of physiological parameters of the anterior chamber and Measurements of the Axial biometry
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
378 participants
Where
1 siteFrance
Study dates
10 Jun 2024to Aug 2025
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 4 years and older
  • All sexes
  • Healthy volunteers accepted
  • Child, Adult, Older adult

Who may be able to join

  • Adults ≥ 18 years old and Healthy children ≥ 4 years and <18 of age.
  • Participants initially coming to the center for a routine consultation
  • Participants who are affiliated to a social security scheme or beneficiaries of such a scheme (L. 1121-8-1 of the Public Health Code of "Code de Santé Publique"),
  • Participants able to sit upright in front of the investigational device.
  • Healthy children ≥ 4 years and <18 of age. The parents must have consented to their child's participation.
  • Children who are affiliated to parent's social security scheme or beneficiaries of such a scheme (L. 1121-8-1 of the Public Health Code of "Code de Santé Publique")
  • Children initially coming to the center for a routine consultation
  • Children able to sit upright in front of the instrument.

Who cannot join

  • Participants with implanted electronic medical device such as pacemaker, insulin pump, cochlear implant, electrostimulator or hearing aid,
  • Participants not able to sit upright in front of the instrument or subjects with forehead or chin injuries which prevent the head from being supported on the forehead / chin rest.
  • Participants who are deprived of their liberty by judicial or administrative decision and persons hospitalized without their consent (Article L. 1121-6 of "Code de Santé Publique"),
  • Participants who are subject to a legal protection measure (curatorship, guardianship, safeguard of justice ...) or unable to express their consent (Article L1121-8 of "Code de Santé Publique"),
  • Participants who are not affiliated to a social security scheme or beneficiaries of such a scheme (L. 1121-8-1 of the Public Health Code of "Code de Santé Publique"),
  • Participants under exclusion period from another investigation,
Show all 28Show fewer
  • Women who are pregnant or breastfeeding women; (Article L1121-5 of "Code de Santé Publique"). No additional risk had been identified for pregnant woman in participating in the investigation. Nevertheless, pregnancy induces ocular changes: in case of AE, the causality with the device or with pregnancy may be difficult to establish, justifying the non-inclusion of this population.
  • Participants with neurologic disorder, particularly epileptic or sensory motor troubles,
  • Participants with history of recent ocular surgeries (including refractive surgery less than 2 weeks),
  • Participants who are ESSILOR International/ESSILOR Luxottica employees,
  • Participants with monophthalmia,
  • Participants with obvious fixation disorder, strabismus, or nystagmus,
  • For tonometry measurements: subjects who have: Edematous/ulcerated cornea, following keratoplasty or ocular surgery, following penetrating trauma, severe Keratoconus with risk of hydrops and in case of retinal detachment. Anterior and posterior chamber sulcus IOL, intrastromal rings or lens (type Kamra).
  • Participants with pupil < 2 mm,
  • Participants who are with spherical equivalent refraction out of the range -20.00 to + 20.00 D (frontofocometer measurement),
  • Participants with an astigmatism greater than 8.00 D (<8.00 D) (frontofocometer measurement),
  • Participants with corneal power out of the range [35-55D],
  • Participants with axial length out of the range [18-34 mm],
  • Participants with Intraocular pressure out of [7-50 mm Hg] range,
  • Participants to a previous phase of this clinical investigation.
  • Children with neurologic disorders, particularly epileptic or sensory motor troubles,
  • Children with history of recent ocular surgeries (including refractive surgery less than two weeks)
  • Children with monophthalmia,
  • Children with obvious fixation disorder, strabismus, or nystagmus,
  • Children with pupil < 2 mm
  • Children with a spherical equivalent refraction out of the range [-20.00 to + 20.00 D] (frontofocometer measurement),
  • Children with an astigmatism higher than 8.00 D (>8.00 D)
  • Children with axial length out of the range [18-34 mm]

Trial locations and contacts

1 site in 1 country.

Paul-Henri Prevot contact

+33 1 72 94 70 09

prevotph@essilor.fr

France1 site, 1 recruiting
  • West Ophta

    Rennes, 35000

    FRANCOIS LE GUYADER, Dr

    PIERRE-EMMANUEL ARCADE, Dr

    Recruiting

Other trials in France

About this study

Official title: Development Clinical Investigation for a Multifunction Ophthalmic Measurement Device

The purpose of this clinical investigation is to evaluate the clinical utility of a multifunctional measuring device for Ophtalmology.

The results of this clinical investigation will be used to refine and validate the device design.

378 participants total will be included in the trial, each having only one visit at the investigation center.

Read the detailed description

The objectives of this clinical investigation are:

  • Develop the device in clinical conditions (refine the intensity and gain of the light sources and the acquisition time of the cameras and photodiodes, in order to cover the targeted population).
  • Evaluate the safety and clinical performance and/or effectiveness of the medical device and determine whether the system is suitable for the purposes and populations for which it is intended.
Being tested
Measurements of physiological parameters of the anterior chamber, Measurements of the Axial biometry
Medical subject headings
Keratoconus, Dry Eye Syndromes, Refractive Errors, Corneal Wavefront Aberration

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Measurements of physiological parameters of the anterior chamberDevice

    Acquisition by the investigational device

  • Measurements of the Axial biometryDevice

    Acquisition by the investigational device

Study groups in NCT06565091
Study groupRoleWhat they receive
Multifonction Ophtalmic Measuring DeviceExperimentalParameters and images of the anterior and posterior chambers of the human eye
Receives: Device: Measurements of physiological parameters of the anterior chamber; Device: Measurements of the Axial biometry

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Relative frequency of successful acquisition for each measurement of the investigational device

    Measured: One day (measurements are taken during the single visit)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted21 Aug 2024
  2. Study start10 Jun 2024
  3. Primary completionAug 2025 (estimated)
  4. Study completionAug 2025 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Diagnosis
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
378 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06565091
Sponsor's protocol ID
WS10339
Other IDs
2023-A01481-44
Status last verified
Aug 2024
First submitted
19 Aug 2024
Last updated
21 Aug 2024
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing Measurements of physiological parameters of the anterior chamber and Measurements of the Axial biometry in people with Accommodation Disorder and Keratoconus, run by Essilor International at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 8 inclusion and 28 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 21 Aug 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Paul-Henri Prevot (+33 1 72 94 70 09, prevotph@essilor.fr), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Relative frequency of successful acquisition for each measurement of the investigational device (time frame: One day (measurements are taken during the single visit)). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 21 Aug 2024.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in